Zacks Research Has Negative Outlook of Surmodics Q3 Earnings
Surmodics, Inc. (NASDAQ:SRDX – Free Report) – Investment analysts at Zacks Research cut their Q3 2025 earnings per share estimates for Surmodics in a research note issued on Tuesday, May 27th. Zacks Research analyst D. Dey now expects that the company will earn ($0.21) per share for the quarter, down from their prior estimate of […]
Surmodics, Inc. (NASDAQ:SRDX – Free Report) – Investment analysts at Zacks Research cut their Q3 2025 earnings per share estimates for Surmodics in a research note issued on Tuesday, May 27th. Zacks Research analyst D. Dey now expects that the company will earn ($0.21) per share for the quarter, down from their prior estimate of […]
